Literature DB >> 1690756

Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide.

G Boire1, J Craft.   

Abstract

Anti-Ro autoantibodies, found in sera of patients with systemic lupus erythematosus, Sjogren's syndrome, and related diseases, target the Ro ribonucleoprotein particles (RNPs). Although the polypeptide and RNA components of the Ro RNPs have been characterized, much less is known about the native structure of these particles. We have now characterized by biochemical techniques intact Ro ribonucleoprotein particles from cultured HeLa cells. These particles segregated in three discrete subpopulations with characteristic physicochemical properties: one containing hY5 RNA (RohY5 particles), one containing only hY4 RNA (RohY4 particles) and one with hY1, hY3, and hY4 RNAs (RohY1-hY4 particles). The RohY5 particles were purified free of contaminating ribonucleoproteins; both the La and the 60-kD Ro polypeptides were stable components of this portion of the Ro RNPs. The La RNPs co-purified with the RohY4 particles and contaminated the RohY1-hY4 RNPs. The stable association between the La and the 60-kD Ro polypeptides provides a potential macromolecular target for the linked set of anti-Ro and anti-La antibodies, and suggests a possible functional association of these polypeptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690756      PMCID: PMC296550          DOI: 10.1172/JCI114551

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Association between the Ro and La antigenic determinants: immunodiffusion analysis of human spleen extract.

Authors:  R A Eisenberg
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

Review 2.  Significance of the Ro antigen system.

Authors:  M Reichlin
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

3.  Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus.

Authors:  K Elkon; S Skelly; A Parnassa; W Moller; W Danho; H Weissbach; N Brot
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells.

Authors:  M D Rader; C O'Brien; Y S Liu; J B Harley; M Reichlin
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

Review 5.  Autoantibodies to ribonucleoproteins.

Authors:  J A Hardin; T Mimori
Journal:  Clin Rheum Dis       Date:  1985-12

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Biochemical and immunological heterogeneity of the Ro ribonucleoprotein particles. Analysis with sera specific for the RohY5 particle.

Authors:  G Boire; J Craft
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 8.  Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.

Authors:  E M Tan; E K Chan; K F Sullivan; R L Rubin
Journal:  Clin Immunol Immunopathol       Date:  1988-05

9.  Characteristics and epitope mapping of a cloned human autoantigen La.

Authors:  A D Sturgess; M G Peterson; L J McNeilage; S Whittingham; R L Coppel
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

10.  The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase.

Authors:  J Van de Water; M E Gershwin; P Leung; A Ansari; R L Coppel
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  27 in total

1.  Specificity of autoantibodies to SS-A/Ro on a transfected and overexpressed human 60 kDa Ro autoantigen substrate.

Authors:  Marvin J Fritzler; Cheryl Hanson; Joan Miller; Theophany Eystathioy
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

Review 2.  B-cell epitopes of La and Ro autoantigens.

Authors:  S Whittingham
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

3.  Analysis of protein--RNA interactions within Ro ribonucleoprotein complexes.

Authors:  G J Pruijn; R L Slobbe; W J van Venrooij
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

Review 4.  Autoantibodies to the RoRNP particles.

Authors:  M Reichlin
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

5.  Molecular composition of Ro small ribonucleoprotein complexes in human cells. Intracellular localization of the 60- and 52-kD proteins.

Authors:  A Kelekar; M R Saitta; J D Keene
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

Review 6.  Structure and function of La and Ro RNPs.

Authors:  W J van Venrooij; R L Slobbe; G J Pruijn
Journal:  Mol Biol Rep       Date:  1993-08       Impact factor: 2.316

7.  The ultrastructural localization of 60-kDa Ro protein and human cytoplasmic RNAs: association with novel electron-dense bodies.

Authors:  A D Farris; F Puvion-Dutilleul; E Puvion; J B Harley; L A Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

8.  Calreticulin synthetic peptide analogues: anti-peptide antibodies in autoimmune rheumatic diseases.

Authors:  J G Routsias; A G Tzioufas; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

9.  Human autoantibodies directed against the RNA recognition motif of La (SS-B) bind to a conformational epitope present on the intact La (SS-B)/Ro (SS-A) ribonucleoprotein particle.

Authors:  M Rischmueller; L J McNeilage; J McCluskey; T Gordon
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

10.  Prognostic value of Sjögren's syndrome autoantibodies.

Authors:  R Hal Scofield; Anum Fayyaz; Biji T Kurien; Kristi A Koelsch
Journal:  J Lab Precis Med       Date:  2018-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.